AxioMed Spine Corporation Adds Larry Papasan To Board of Directors.GARFIELD HEIGHTS, Ohio -- AxioMed([R]) Spine Corporation (ASC ASC Ambulatory surgery center, see there ) announced today that Larry W. Papasan has joined the company's Board of Directors. Mr. Papasan is the former President of Smith & Nephew Orthopedics, a division of Smith & Nephew, plc (LSE LSE - Language Sensitive Editor : SN, NYSE NYSE See: New York Stock Exchange : SNN) and is currently Chairman of the Board of BioMimetic Therapeutics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BMTI BMTI Block Mode Terminal Interface ) as well as holding other board positions in commercial and community service organizations. During his tenure as President of the Smith & Nephew Orthopedics division sales grew from $300 million to $650 million while achieving profitability at over 15% per year. Peter Kleinhenz, Managing Director of CID Cid or Cid Campeador (sĭd, Span. thēth kämpāäthōr`) [Span.,=lord conqueror], d. 1099, Spanish soldier and national hero, whose real name was Rodrigo (or Ruy) Díaz de Vivar. Capital and Chairman of the Board of AxioMed stated, "We were delighted that Larry agreed to join the ASC Board. His extensive experience in orthopedics worldwide and demonstrated board skills will be a significant asset to the company." Patrick McBrayer, AxioMed's President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. stated, "I have had the good fortune to work for Larry following Smith & Nephew's acquisition of my former company, Exogen, Inc. He has a stellar reputation as a leader who has successfully built medical companies and introduced new technologies. AxioMed will significantly benefit from his breadth of business and orthopedic experience." Mr. Papasan stated, "I am very impressed with AxioMed and its team which has extensive spine experience. The company's next generation total disc replacement for the spine is already in pilot clinical trials and has excellent prospects. I look forward to assisting them in building a significant company in spine care." About AxioMed AxioMed's mission is to develop products that restore the natural function to patients with degenerative spine disease, thus advancing the standard of care beyond fusion and first generation discs. The Freedom([R]) disc was developed and designed by a team of clinicians and experts in the fields of biomechanics, pathology, spinal surgery and polymer science. Freedom([R]) is currently in pilot clinical trials in Europe. Contact: Patrick McBrayer, President and CEO AxioMed Spine Corporation pmcbrayer@axiomed.com 5350 Transportation Blvd. Suite 18 Garfield, Heights, OH 44125 216-587-5566 www.axiomed.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion